BSEM - BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday May 14 2024 | Benzinga
POMPANO BEACH, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading biotechnology company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, announced today that it plans to release its first quarter 2024 financial results post-market on Tuesday, May 14, 2024.
BioStem will host a conference call and webcast at 4:30 pm ET on Tuesday, May 14, 2024. The call will include a discussion of first quarter 2024 financial results and a corporate update.
The live call can be accessed by dialing USA / International Toll +1 .646.968.2525
USA - Toll-Free +1.888.596.4144
The live and archived webcast of the call will also be available on the BioStem Technologies website under the Investors section or by following this link: https://events.q4inc.com/attendee/274186276
About BioStem Technologies, Inc. (OTC:BSEM):?BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and ...